Advertisement
Adult: AATS Expert Consensus Document: Coronary Artery Bypass Grafting in Patients With Ischemic Cardiomyopathy and Heart Failure| Volume 162, ISSUE 3, P829-850.e1, September 01, 2021

2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure

      This expert consensus is on managing patients with ischemic cardiomyopathy, including triggers for specialized heart failure care, choice of surgical interventions, and measures to improve outcomes.

      Key Words

      Abbreviations and Acronyms:

      AATS (American Association for Thoracic Surgery), AF (atrial fibrillation), CABG (coronary artery bypass grafting), CAD (coronary artery disease), CRT (cardiac resynchronization therapy), GDMT (guideline-directed medical therapy), HF (heart failure), HFrEF (heart failure with reduced ejection fraction), IABP (intra-aortic balloon pump), ICD (implantable cardioverter-defibrillator), ICM (ischemic cardiomyopathy), LAA (left atrial appendage), LGE-CMR (late gadolinium enhancement cardiac magnetic resonance), LV (left ventricle/ventricular), LVEF (left ventricular ejection fraction), LVESVI (left ventricular end-systolic volume index), MAG (multiarterial grafting), MCS (mechanical circulatory support), MR (mitral regurgitation), NYHA (New York Heart Association), PCI (percutaneous coronary intervention), PCS (postcardiotomy shock), RCT (randomized controlled trial), RV (right ventricle/ventricular), STICH (Surgical Treatment for Ischemic Heart Failure), STS (Society of Thoracic Surgeons), SVR (surgical ventricular restoration), TR (tricuspid regurgitation), VAD (ventricular assist device), VA-ECMO (veno-arterial extracorporeal membrane oxygenation), VT (ventricular tachycardia)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Thoracic and Cardiovascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Khan M.A.
        • Hashim M.J.
        • Mustafa H.
        • Baniyas M.Y.
        • Al Suwaidi S.
        • AlKatheeri R.
        • et al.
        Global epidemiology of ischemic heart disease: results from the global burden of disease study.
        Cureus. 2020; 12: e9349
        • Virani S.S.
        • Alonso A.
        • Aparicio H.J.
        • Benjamin E.J.
        • Bittencourt M.S.
        • Callaway C.W.
        • et al.
        Heart disease and stroke statistics–2021 update: a report from the American Heart Association.
        Circulation. 2021; 143: e254-e743
        • Elgendy I.Y.
        • Mahtta D.
        • Pepine C.J.
        Medical therapy for heart failure caused by ischemic heart disease.
        Circ Res. 2019; 124: 1520-1535
        • Heidenreich P.A.
        • Albert N.M.
        • Allen L.A.
        • Bluemke D.A.
        • Butler J.
        • Fonarow G.C.
        • et al.
        Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association.
        Circ Heart Fail. 2013; 6: 606-619
        • Yancy C.W.
        • Jessup M.
        • Bozkurt B.
        • Butler J.
        • Casey Jr., D.E.
        • Drazner M.H.
        • et al.
        2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines.
        J Am Coll Cardiol. 2013; 62: e147-e239
        • Kron I.L.
        • Acker M.A.
        • Adams D.H.
        • Ailawadi G.
        • Bolling S.F.
        • Hung J.W.
        • et al.
        2015 American Association for Thoracic Surgery consensus guidelines: ischemic mitral valve regurgitation.
        J Thorac Cardiovasc Surg. 2016; 151: 940-956
        • Hillis L.D.
        • Smith P.K.
        • Anderson J.L.
        • Bittl J.A.
        • Bridges C.R.
        • Byrne J.G.
        • et al.
        2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines.
        J Thorac Cardiovasc Surg. 2012; 143: 4-34
        • Aldea G.S.
        • Bakaeen F.G.
        • Pal J.
        • Fremes S.
        • Head S.J.
        • Sabik J.
        • et al.
        The Society of Thoracic Surgeons clinical practice guidelines on arterial conduits for coronary artery bypass grafting.
        Ann Thorac Surg. 2016; 101: 801-809
        • Neumann F.J.
        • Sousa-Uva M.
        • Ahlsson A.
        • Alfonso F.
        • Banning A.P.
        • Benedetto U.
        • et al.
        2018 ESC/EACTS guidelines on myocardial revascularization.
        Eur Heart J. 2019; 40: 87-165
        • Epstein A.E.
        • DiMarco J.P.
        • Ellenbogen K.A.
        • Estes III, N.A.
        • Freedman R.A.
        • Gettes L.S.
        • et al.
        ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons.
        J Am Coll Cardiol. 2008; 51: e1-e62
        • Yancy C.W.
        • Jessup M.
        • Bozkurt B.
        • Butler J.
        • Casey Jr., D.E.
        • Colvin M.M.
        • et al.
        2017 ACC/AHA/HFSA focused update of the 2013 accf/aha guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America.
        J Am Coll Cardiol. 2017; 70: 776-803
        • Maddox T.M.
        • Januzzi Jr., J.L.
        • Allen L.A.
        • Breathett K.
        • Butler J.
        • Davis L.L.
        • et al.
        2021 update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of Cardiology solution set oversight committee.
        J Am Coll Cardiol. 2021; 77: 772-810
        • Kron I.L.
        • LaPar D.J.
        • Acker M.A.
        • Adams D.H.
        • Ailawadi G.
        • Bolling S.F.
        • et al.
        2016 update to the American Association for Thoracic Surgery consensus guidelines: ischemic mitral valve regurgitation.
        J Thorac Cardiovasc Surg. 2017; 153: 1076-1079
        • Epstein A.E.
        • DiMarco J.P.
        • Ellenbogen K.A.
        • Estes III, N.A.
        • Freedman R.A.
        • Gettes L.S.
        • et al.
        2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Heart Rhythm Society.
        J Am Coll Cardiol. 2013; 61: e6-e75
        • Bakaeen F.G.
        • Svensson L.G.
        • Mitchell J.D.
        • Keshavjee S.
        • Patterson G.A.
        • Weisel R.D.
        The American Association for Thoracic Surgery/Society of Thoracic Surgeons position statement on developing clinical practice documents.
        J Thorac Cardiovasc Surg. 2017; 153: 999-1005
        • Garcia M.J.
        • Kwong R.Y.
        • Scherrer-Crosbie M.
        • Taub C.C.
        • Blankstein R.
        • Lima J.
        • et al.
        State of the art: imaging for myocardial viability: a scientific statement from the American Heart Association.
        Circ Cardiovasc Imaging. 2020; 13: e000053
        • Hwang H.Y.
        • Yeom S.Y.
        • Park E.A.
        • Lee W.
        • Jang M.J.
        • Kim K.B.
        Serial cardiac magnetic resonance imaging after surgical coronary revascularization for left ventricular dysfunction.
        J Thorac Cardiovasc Surg. 2020; 159: 1798-1805
        • Panza J.A.
        • Holly T.A.
        • Asch F.M.
        • She L.
        • Pellikka P.A.
        • Velazquez E.J.
        • et al.
        Inducible myocardial ischemia and outcomes in patients with coronary artery disease and left ventricular dysfunction.
        J Am Coll Cardiol. 2013; 61: 1860-1870
        • Panza J.A.
        • Ellis A.M.
        • Al-Khalidi H.R.
        • Holly T.A.
        • Berman D.S.
        • Oh J.K.
        • et al.
        Myocardial viability and long-term outcomes in ischemic cardiomyopathy.
        N Engl J Med. 2019; 381: 739-748
        • Beanlands R.S.
        • Nichol G.
        • Huszti E.
        • Humen D.
        • Racine N.
        • Freeman M.
        • et al.
        F-18-Fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease (PARR-2): a randomized, controlled trial.
        J Am Coll Cardiol. 2007; 50: 2002-2012
        • Orlandini A.
        • Castellana N.
        • Pascual A.
        • Botto F.
        • Cecilia Bahit M.
        • Chacon C.
        • et al.
        Myocardial viability for decision-making concerning revascularization in patients with left ventricular dysfunction and coronary artery disease: a meta-analysis of non-randomized and randomized studies.
        Int J Cardiol. 2015; 182: 494-499
        • Stentz M.J.
        • Kelley M.E.
        • Jabaley C.S.
        • O'Reilly-Shah V.
        • Groff R.F.
        • Moll V.
        • et al.
        Trends in extracorporeal membrane oxygenation growth in the United States, 2011-2014.
        ASAIO J. 2019; 65: 712-717
        • Simons J.
        • Suverein M.
        • van Mook W.
        • Caliskan K.
        • Soliman O.
        • van de Poll M.
        • et al.
        Do-(not-) mechanical-circulatory-support orders: should we ask all cardiac surgery patients for informed consent for post-cardiotomy extracorporeal life circulatory support?.
        J Clin Med. 2021; 10: 383
        • Wolff G.
        • Dimitroulis D.
        • Andreotti F.
        • Kolodziejczak M.
        • Jung C.
        • Scicchitano P.
        • et al.
        Survival benefits of invasive versus conservative strategies in heart failure in patients with reduced ejection fraction and coronary artery disease: a meta-analysis.
        Circ Heart Fail. 2017; 10: e003255
        • Velazquez E.J.
        • Lee K.L.
        • Deja M.A.
        • Jain A.
        • Sopko G.
        • Marchenko A.
        • et al.
        Coronary-artery bypass surgery in patients with left ventricular dysfunction.
        N Engl J Med. 2011; 364: 1607-1616
        • Sedlis S.P.
        • Ramanathan K.B.
        • Morrison D.A.
        • Sethi G.
        • Sacks J.
        • Henderson W.
        Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME randomized trial and registry).
        Am J Cardiol. 2004; 94: 118-120
        • Cleland J.G.
        • Calvert M.
        • Freemantle N.
        • Arrow Y.
        • Ball S.G.
        • Bonser R.S.
        • et al.
        The Heart Failure Revascularisation Trial (HEART).
        Eur J Heart Fail. 2011; 13: 227-233
        • Velazquez E.J.
        • Lee K.L.
        • Jones R.H.
        • Al-Khalidi H.R.
        • Hill J.A.
        • Panza J.A.
        • et al.
        Coronary-artery bypass surgery in patients with ischemic cardiomyopathy.
        N Engl J Med. 2016; 374: 1511-1520
        • Bangalore S.
        • Guo Y.
        • Samadashvili Z.
        • Blecker S.
        • Hannan E.L.
        Revascularization in patients with multivessel coronary artery disease and severe left ventricular systolic dysfunction: everolimus-eluting stents versus coronary artery bypass graft surgery.
        Circulation. 2016; 133: 2132-2140
        • Sun L.Y.
        • Gaudino M.
        • Chen R.J.
        • Bader Eddeen A.
        • Ruel M.
        Long-term outcomes in patients with severely reduced left ventricular ejection fraction undergoing percutaneous coronary intervention vs coronary artery bypass grafting.
        JAMA Cardiol. 2020; 5: 631-641
        • Melby S.J.
        • Saint L.L.
        • Balsara K.
        • Itoh A.
        • Lawton J.S.
        • Maniar H.
        • et al.
        Complete coronary revascularization improves survival in octogenarians.
        Ann Thorac Surg. 2016; 102: 505-511
        • Nagendran J.
        • Bozso S.J.
        • Norris C.M.
        • McAlister F.A.
        • Appoo J.J.
        • Moon M.C.
        • et al.
        Coronary artery bypass surgery improves outcomes in patients with diabetes and left ventricular dysfunction.
        J Am Coll Cardiol. 2018; 71: 819-827
        • Vickneson K.
        • Chan S.P.
        • Li Y.
        • Bin Abdul Aziz M.N.
        • Luo H.D.
        • Kang G.S.
        • et al.
        Coronary artery bypass grafting in patients with low ejection fraction: what are the risk factors?.
        J Cardiovasc Surg (Torino). 2019; 60: 396-405
        • Kusu-Orkar T.E.
        • Kermali M.
        • Oguamanam N.
        • Bithas C.
        • Harky A.
        Coronary artery bypass grafting: factors affecting outcomes.
        J Card Surg. 2020; 35: 3503-3511
        • O'Brien S.M.
        • Feng L.
        • He X.
        • Xian Y.
        • Jacobs J.P.
        • Badhwar V.
        • et al.
        The Society of Thoracic Surgeons 2018 adult cardiac surgery risk models: part 2—statistical methods and results.
        Ann Thorac Surg. 2018; 105: 1419-1428
        • Pichette M.
        • Liszkowski M.
        • Ducharme A.
        Preoperative optimization of the heart failure patient undergoing cardiac surgery.
        Can J Cardiol. 2017; 33: 72-79
        • Christenson J.T.
        • Schmuziger M.
        • Simonet F.
        Effective surgical management of high-risk coronary patients using preoperative intra-aortic balloon counterpulsation therapy.
        Cardiovasc Surg. 2001; 9: 383-390
        • Sá M.P.
        • Ferraz P.E.
        • Escobar R.R.
        • Martins W.N.
        • Nunes E.O.
        • Vasconcelos F.P.
        • Lima R.C.
        Prophylactic intra-aortic balloon pump in high-risk patients undergoing coronary artery bypass surgery: a meta-analysis of randomized controlled trials.
        Coron Artery Dis. 2012; 23: 480-486
        • Pilarczyk K.
        • Boening A.
        • Jakob H.
        • Langebartels G.
        • Markewitz A.
        • Haake N.
        • et al.
        Preoperative intra-aortic counterpulsation in high-risk patients undergoing cardiac surgery: a meta-analysis of randomized controlled trialsdagger.
        Eur J Cardiothorac Surg. 2016; 49: 5-17
        • Ramzy D.
        • Soltesz E.
        • Anderson M.
        New surgical circulatory support system outcomes.
        ASAIO J. 2020; 66: 746-752
        • Akay M.H.
        • Frazier O.H.
        Impella Recover 5.0 assisted coronary artery bypass grafting.
        J Card Surg. 2010; 25: 606-607
        • Ranganath N.K.
        • Nafday H.B.
        • Zias E.
        • Hisamoto K.
        • Chen S.
        • Kon Z.N.
        • et al.
        Concomitant temporary mechanical support in high-risk coronary artery bypass surgery.
        J Card Surg. 2019; 34: 1569-1572
        • Bakaeen F.G.
        • Shroyer A.L.
        • Gammie J.S.
        • Sabik J.F.
        • Cornwell L.D.
        • Coselli J.S.
        • et al.
        Trends in use of off-pump coronary artery bypass grafting: results from the Society of Thoracic Surgeons adult cardiac surgery database.
        J Thorac Cardiovasc Surg. 2014; 148 (864.e1; discussion 863-4): 856-863
        • Patel V.
        • Unai S.
        • Gaudino M.
        • Bakaeen F.
        Current readings on outcomes after off-pump coronary artery bypass grafting.
        Semin Thorac Cardiovasc Surg. 2019; 31: 726-733
        • Zeng J.
        • He W.
        • Qu Z.
        • Tang Y.
        • Zhou Q.
        • Zhang B.
        Cold blood versus crystalloid cardioplegia for myocardial protection in adult cardiac surgery: a meta-analysis of randomized controlled studies.
        J Cardiothorac Vasc Anesth. 2014; 28: 674-681
        • Fan Y.
        • Zhang A.M.
        • Xiao Y.B.
        • Weng Y.G.
        • Hetzer R.
        Warm versus cold cardioplegia for heart surgery: a meta-analysis.
        Eur J Cardiothorac Surg. 2010; 37: 912-919
        • Gambardella I.
        • Gaudino M.F.L.
        • Antoniou G.A.
        • Rahouma M.
        • Worku B.
        • Tranbaugh R.F.
        • et al.
        Single- versus multidose cardioplegia in adult cardiac surgery patients: a meta-analysis.
        J Thorac Cardiovasc Surg. 2020; 160: 1195-1202.e12
        • Siddiqi S.
        • Blackstone E.H.
        • Bakaeen F.G.
        Bretschneider and del Nido solutions: are they safe for coronary artery bypass grafting? If so, how should we use them?.
        J Card Surg. 2018; 33: 229-234
        • Gaudino M.
        • Pragliola C.
        • Anselmi A.
        • Pieroni M.
        • De Paulis S.
        • Leone A.
        • et al.
        Randomized trial of HTK versus warm blood cardioplegia for right ventricular protection in mitral surgery.
        Scand Cardiovasc J. 2013; 47: 359-367
        • Oriaku G.
        • Xiang B.
        • Dai G.
        • Shen J.
        • Sun J.
        • Lindsay W.G.
        • et al.
        Effects of retrograde cardioplegia on myocardial perfusion and energy metabolism in immature porcine myocardium.
        J Thorac Cardiovasc Surg. 2000; 119: 1102-1109
        • Borger M.A.
        • Rao V.
        • Weisel R.D.
        • Floh A.A.
        • Cohen G.
        • Feindel C.M.
        • et al.
        Reoperative coronary bypass surgery: effect of patent grafts and retrograde cardioplegia.
        J Thorac Cardiovasc Surg. 2001; 121: 83-90
        • Sharifi M.
        • Mousavi S.R.
        • Rafiei M.
        Our modified technique of combined antegrade-vein graft cardioplegia infusion versus conventional antegrade method in coronary artery bypass grafting. A randomized clinical trial.
        Int J Surg. 2018; 55: 53-59
        • Puskas J.D.
        • Gaudino M.
        • Taggart D.P.
        Experience is crucial in off-pump coronary artery bypass grafting.
        Circulation. 2019; 139: 1872-1875
        • Jarral O.A.
        • Saso S.
        • Athanasiou T.
        Off-pump coronary artery bypass in patients with left ventricular dysfunction: a meta-analysis.
        Ann Thorac Surg. 2011; 92: 1686-1694
        • Guan Z.
        • Guan X.
        • Gu K.
        • Lin X.
        • Lin J.
        • Zhou W.
        • et al.
        Short-term outcomes of on- vs off-pump coronary artery bypass grafting in patients with left ventricular dysfunction: a systematic review and meta-analysis.
        J Cardiothorac Surg. 2020; 15: 84
        • Ueki C.
        • Miyata H.
        • Motomura N.
        • Sakaguchi G.
        • Akimoto T.
        • Takamoto S.
        Off-pump versus on-pump coronary artery bypass grafting in patients with left ventricular dysfunction.
        J Thorac Cardiovasc Surg. 2016; 151: 1092-1098
        • Al Jaaly E.
        • Chaudhry U.A.
        • Harling L.
        • Athanasiou T.
        Should we consider beating-heart on-pump coronary artery bypass grafting over conventional cardioplegic arrest to improve postoperative outcomes in selected patients?.
        Interact Cardiovasc Thorac Surg. 2015; 20: 538-545
        • Pegg T.J.
        • Selvanayagam J.B.
        • Francis J.M.
        • Karamitsos T.D.
        • Maunsell Z.
        • Yu L.M.
        • et al.
        A randomized trial of on-pump beating heart and conventional cardioplegic arrest in coronary artery bypass surgery patients with impaired left ventricular function using cardiac magnetic resonance imaging and biochemical markers.
        Circulation. 2008; 118: 2130-2138
        • Gaudino M.
        • Benedetto U.
        • Taggart D.P.
        Radial-artery grafts for coronary-artery bypass surgery.
        N Engl J Med. 2018; 379: 1967-1968
        • Pu A.
        • Ding L.
        • Shin J.
        • Price J.
        • Skarsgard P.
        • Wong D.R.
        • et al.
        Long-term outcomes of multiple arterial coronary artery bypass grafting: a population-based study of patients in British Columbia, Canada.
        JAMA Cardiol. 2017; 2: 1187-1196
        • Weiss A.J.
        • Zhao S.
        • Tian D.H.
        • Taggart D.P.
        • Yan T.D.
        A meta-analysis comparing bilateral internal mammary artery with left internal mammary artery for coronary artery bypass grafting.
        Ann Cardiothorac Surg. 2013; 2: 390-400
        • Shahian D.M.
        • O'Brien S.M.
        • Filardo G.
        • Ferraris V.A.
        • Haan C.K.
        • Rich J.B.
        • et al.
        The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1—coronary artery bypass grafting surgery.
        Ann Thorac Surg. 2009; 88: S2-S22
        • He G.W.
        • Taggart D.P.
        Spasm in arterial grafts in coronary artery bypass grafting surgery.
        Ann Thorac Surg. 2016; 101: 1222-1229
        • Silva M.
        • Rong L.Q.
        • Naik A.
        • Rahouma M.
        • Hameed I.
        • Robinson B.
        • et al.
        Intraoperative graft flow profiles in coronary artery bypass surgery: a meta-analysis.
        J Card Surg. 2020; 35: 279-285
        • Jones E.L.
        • Lattouf O.M.
        • Weintraub W.S.
        Catastrophic consequences of internal mammary artery hypoperfusion.
        J Thorac Cardiovasc Surg. 1989; 98: 902-907
        • Navia D.
        • Cosgrove III, D.M.
        • Lytle B.W.
        • Taylor P.C.
        • McCarthy P.M.
        • Stewart R.W.
        • et al.
        Is the internal thoracic artery the conduit of choice to replace a stenotic vein graft?.
        Ann Thorac Surg. 1994; 57: 40-44
        • Gaudino M.
        • Benedetto U.
        • Fremes S.
        • Biondi-Zoccai G.
        • Sedrakyan A.
        • Puskas J.D.
        • et al.
        Radial-artery or saphenous-vein grafts in coronary-artery bypass surgery.
        N Engl J Med. 2018; 378: 2069-2077
        • Lytle B.W.
        • Blackstone E.H.
        • Sabik J.F.
        • Houghtaling P.
        • Loop F.D.
        • Cosgrove D.M.
        The effect of bilateral internal thoracic artery grafting on survival during 20 postoperative years.
        Ann Thorac Surg. 2004; 78: 2005-2014
        • Schwann T.A.
        • Al-Shaar L.
        • Tranbaugh R.F.
        • Dimitrova K.R.
        • Hoffman D.M.
        • Geller C.M.
        • et al.
        Multi versus single arterial coronary bypass graft surgery across the ejection fraction spectrum.
        Ann Thorac Surg. 2015; 100: 810-818
        • Samadashvili Z.
        • Sundt III, T.M.
        • Wechsler A.
        • Chikwe J.
        • Adams D.H.
        • Smith C.R.
        • et al.
        Multiple versus single arterial coronary bypass graft surgery for multivessel disease.
        J Am Coll Cardiol. 2019; 74: 1275-1285
        • Chikwe J.
        • Sun E.
        • Hannan E.L.
        • Itagaki S.
        • Lee T.
        • Adams D.H.
        • et al.
        Outcomes of second arterial conduits in patients undergoing multivessel coronary artery bypass graft surgery.
        J Am Coll Cardiol. 2019; 74: 2238-2248
        • Mohammadi S.
        • Kalavrouziotis D.
        • Cresce G.
        • Dagenais F.
        • Dumont E.
        • Charbonneau E.
        • et al.
        Bilateral internal thoracic artery use in patients with low ejection fraction: is there any additional long-term benefit?.
        Eur J Cardiothorac Surg. 2014; 46: 425-431
        • Gaudino M.
        • Bakaeen F.
        • Benedetto U.
        • Rahouma M.
        • Di Franco A.
        • Tam D.Y.
        • et al.
        Use rate and outcome in bilateral internal thoracic artery grafting: insights from a systematic review and meta-analysis.
        J Am Heart Assoc. 2018; 7: e009361
        • Benedetto U.
        • Codispoti M.
        Age cutoff for the loss of survival benefit from use of radial artery in coronary artery bypass grafting.
        J Thorac Cardiovasc Surg. 2013; 146: 1078-1085
        • Benedetto U.
        • Amrani M.
        • Raja S.G.
        Guidance for the use of bilateral internal thoracic arteries according to survival benefit across age groups.
        J Thorac Cardiovasc Surg. 2014; 148: 2706-2711
        • Gaudino M.
        • Samadashvili Z.
        • Hameed I.
        • Chikwe J.
        • Girardi L.N.
        • Hannan E.L.
        Differences in long-term outcomes after coronary artery bypass grafting using single vs multiple arterial grafts and the association with sex.
        JAMA Cardiol. 2020; 6: 401-409
        • Michler R.E.
        • Smith P.K.
        • Parides M.K.
        • Ailawadi G.
        • Thourani V.
        • Moskowitz A.J.
        • et al.
        Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation.
        N Engl J Med. 2016; 374: 1932-1941
        • Chan K.M.
        • Punjabi P.P.
        • Flather M.
        • Wage R.
        • Symmonds K.
        • Roussin I.
        • et al.
        Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial.
        Circulation. 2012; 126: 2502-2510
        • Fattouch K.
        • Guccione F.
        • Sampognaro R.
        • Panzarella G.
        • Corrado E.
        • Navarra E.
        • et al.
        POINT: efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial.
        J Thorac Cardiovasc Surg. 2009; 138: 278-285
        • Wu A.H.
        • Aaronson K.D.
        • Bolling S.F.
        • Pagani F.D.
        • Welch K.
        • Koelling T.M.
        Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction.
        J Am Coll Cardiol. 2005; 45: 381-387
        • Mihaljevic T.
        • Lam B.K.
        • Rajeswaran J.
        • Takagaki M.
        • Lauer M.S.
        • Gillinov A.M.
        • et al.
        Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation.
        J Am Coll Cardiol. 2007; 49: 2191-2201
        • Benedetto U.
        • Melina G.
        • Roscitano A.
        • Fiorani B.
        • Capuano F.
        • Sclafani G.
        • et al.
        Does combined mitral valve surgery improve survival when compared to revascularization alone in patients with ischemic mitral regurgitation? A meta-analysis on 2479 patients.
        J Cardiovasc Med (Hagerstown). 2009; 10: 109-114
        • Harris K.M.
        • Sundt III, T.M.
        • Aeppli D.
        • Sharma R.
        • Barzilai B.
        Can late survival of patients with moderate ischemic mitral regurgitation be impacted by intervention on the valve?.
        Ann Thorac Surg. 2002; 74: 1468-1475
        • Goldstein D.
        • Moskowitz A.J.
        • Gelijns A.C.
        • Ailawadi G.
        • Parides M.K.
        • Perrault L.P.
        • et al.
        Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation.
        N Engl J Med. 2016; 374: 344-353
        • Nappi F.
        • Lusini M.
        • Spadaccio C.
        • Nenna A.
        • Covino E.
        • Acar C.
        • et al.
        Papillary muscle approximation versus restrictive annuloplasty alone for severe ischemic mitral regurgitation.
        J Am Coll Cardiol. 2016; 67: 2334-2346
        • Fattouch K.
        • Lancellotti P.
        • Castrovinci S.
        • Murana G.
        • Sampognaro R.
        • Corrado E.
        • et al.
        Papillary muscle relocation in conjunction with valve annuloplasty improve repair results in severe ischemic mitral regurgitation.
        J Thorac Cardiovasc Surg. 2012; 143: 1352-1355
        • Haywood N.
        • Mehaffey J.H.
        • Chancellor W.Z.
        • Beller J.P.
        • Speir A.
        • Quader M.
        • et al.
        Burden of tricuspid regurgitation in patients undergoing coronary artery bypass grafting.
        Ann Thorac Surg. 2021; 111: 44-50
        • Bertrand P.B.
        • Overbey J.R.
        • Zeng X.
        • Levine R.A.
        • Ailawadi G.
        • Acker M.A.
        • et al.
        Progression of tricuspid regurgitation after surgery for ischemic mitral regurgitation.
        J Am Coll Cardiol. 2021; 77: 713-724
        • Otto C.M.
        • Nishimura R.A.
        • Bonow R.O.
        • Carabello B.A.
        • Erwin III, J.P.
        • Gentile F.
        • et al.
        2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines.
        J Am Coll Cardiol. 2021; 77: e25-e197
        • Buckberg G.
        • Athanasuleas C.
        • Conte J.
        Surgical ventricular restoration for the treatment of heart failure.
        Nat Rev Cardiol. 2012; 9: 703-716
        • O'Neill J.O.
        • Starling R.C.
        • McCarthy P.M.
        • Albert N.M.
        • Lytle B.W.
        • Navia J.
        • et al.
        The impact of left ventricular reconstruction on survival in patients with ischemic cardiomyopathy.
        Eur J Cardiothorac Surg. 2006; 30: 753-759
        • White H.D.
        • Norris R.M.
        • Brown M.A.
        • Brandt P.W.
        • Whitlock R.M.
        • Wild C.J.
        Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.
        Circulation. 1987; 76: 44-51
        • Athanasuleas C.L.
        • Buckberg G.D.
        • Stanley A.W.
        • Siler W.
        • Dor V.
        • Di Donato M.
        • et al.
        Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation.
        J Am Coll Cardiol. 2004; 44: 1439-1445
        • Jones R.H.
        • Velazquez E.J.
        • Michler R.E.
        • Sopko G.
        • Oh J.K.
        • O'Connor C.M.
        • et al.
        Coronary bypass surgery with or without surgical ventricular reconstruction.
        N Engl J Med. 2009; 360: 1705-1717
        • Isomura T.
        • Hoshino J.
        • Fukada Y.
        • Kitamura A.
        • Katahira S.
        • Kondo T.
        • et al.
        Volume reduction rate by surgical ventricular restoration determines late outcome in ischaemic cardiomyopathy.
        Eur J Heart Fail. 2011; 13: 423-431
        • Buckberg G.D.
        • Athanasuleas C.L.
        • Wechsler A.S.
        • Beyersdorf F.
        • Conte J.V.
        • Strobeck J.E.
        The STICH trial unravelled.
        Eur J Heart Fail. 2010; 12: 1024-1027
        • Di Donato M.
        • Castelvecchio S.
        • Menicanti L.
        End-systolic volume following surgical ventricular reconstruction impacts survival in patients with ischaemic dilated cardiomyopathy.
        Eur J Heart Fail. 2010; 12: 375-381
        • Badhwar V.
        • Rankin J.S.
        • Damiano Jr., R.J.
        • Gillinov A.M.
        • Bakaeen F.G.
        • Edgerton J.R.
        • et al.
        The Society of Thoracic Surgeons 2017 clinical practice guidelines for the surgical treatment of atrial fibrillation.
        Ann Thorac Surg. 2017; 103: 329-341
        • McClure G.R.
        • Belley-Cote E.P.
        • Jaffer I.H.
        • Dvirnik N.
        • An K.R.
        • Fortin G.
        • et al.
        Surgical ablation of atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials.
        Europace. 2018; 20: 1442-1450
        • Malaisrie S.C.
        • McCarthy P.M.
        • Kruse J.
        • Matsouaka R.A.
        • Churyla A.
        • Grau-Sepulveda M.V.
        • et al.
        Ablation of atrial fibrillation during coronary artery bypass grafting: late outcomes in a Medicare population.
        J Thorac Cardiovasc Surg. 2021; 161: 1251-1261
        • Iribarne A.
        • DiScipio A.W.
        • McCullough J.N.
        • Quinn R.
        • Leavitt B.J.
        • Westbrook B.M.
        • et al.
        Surgical atrial fibrillation ablation improves long-term survival: a multicenter analysis.
        Ann Thorac Surg. 2019; 107: 135-142
        • Schneider B.
        • Nazarenus D.
        • Stollberger C.
        A 79-year-old woman with atrial fibrillation and new onset of heart failure.
        ESC Heart Fail. 2019; 6: 570-574
        • Natale A.
        • Raviele A.
        • Al-Ahmad A.
        • Alfieri O.
        • Aliot E.
        • Almendral J.
        • et al.
        Venice chart international consensus document on ventricular tachycardia/ventricular fibrillation ablation.
        J Cardiovasc Electrophysiol. 2010; 21: 339-379
        • Veenhuyzen G.D.
        • Singh S.N.
        • McAreavey D.
        • Shelton B.J.
        • Exner D.V.
        Prior coronary artery bypass surgery and risk of death among patients with ischemic left ventricular dysfunction.
        Circulation. 2001; 104: 1489-1493
        • Moss A.J.
        • Zareba W.
        • Hall W.J.
        • Klein H.
        • Wilber D.J.
        • Cannom D.S.
        • et al.
        Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.
        N Engl J Med. 2002; 346: 877-883
        • Al-Khatib S.M.
        • Hellkamp A.S.
        • Lee K.L.
        • Anderson J.
        • Poole J.E.
        • Mark D.B.
        • et al.
        Implantable cardioverter defibrillator therapy in patients with prior coronary revascularization in the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
        J Cardiovasc Electrophysiol. 2008; 19: 1059-1065
        • Beggs S.A.S.
        • Gardner R.S.
        • McMurray J.J.V.
        Who benefits from a defibrillator? Balancing the risk of sudden versus non-sudden death.
        Curr Heart Fail Rep. 2018; 15: 376-389
        • Al-Khatib S.M.
        • Stevenson W.G.
        • Ackerman M.J.
        • Bryant W.J.
        • Callans D.J.
        • Curtis A.B.
        • et al.
        2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society.
        Heart Rhythm. 2018; 15: e73-e189
        • Penicka M.
        • Bartunek J.
        • Lang O.
        • Medilek K.
        • Tousek P.
        • Vanderheyden M.
        • et al.
        Severe left ventricular dyssynchrony is associated with poor prognosis in patients with moderate systolic heart failure undergoing coronary artery bypass grafting.
        J Am Coll Cardiol. 2007; 50: 1315-1323
        • Pokushalov E.
        • Romanov A.
        • Prohorova D.
        • Cherniavsky A.
        • Goscinska-Bis K.
        • Bis J.
        • et al.
        Coronary artery bypass grafting with concomitant cardiac resynchronisation therapy in patients with ischaemic heart failure and left ventricular dyssynchrony.
        Eur J Cardiothorac Surg. 2010; 38: 773-780
        • Romanov A.
        • Goscinska-Bis K.
        • Bis J.
        • Chernyavskiy A.
        • Prokhorova D.
        • Syrtseva Y.
        • et al.
        Cardiac resynchronization therapy combined with coronary artery bypass grafting in ischaemic heart failure patients: long-term results of the RESCUE study.
        Eur J Cardiothorac Surg. 2016; 50: 36-41
        • Thoren E.
        • Kesek M.
        • Jideus L.
        The effect of concomitant cardiac resynchronization therapy on quality of life in patients with heart failure undergoing cardiac surgery.
        Open Cardiovasc Med J. 2014; 8: 18-22
        • Filsoufi F.
        • Jouan J.
        • Chilkwe J.
        • Rahmanian P.R.
        • Castillo J.
        • Carpentier A.F.
        • et al.
        Results and predictors of early and late outcome of coronary artery bypass graft surgery in patients with ejection fraction less than 20%.
        Arch Cardiovasc Dis. 2008; 101: 547-556
        • Langenburg S.E.
        • Buchanan S.A.
        • Blackbourne L.H.
        • Scheri R.P.
        • Sinclair K.N.
        • Martinez J.
        • et al.
        Predicting survival after coronary revascularization for ischemic cardiomyopathy.
        Ann Thorac Surg. 1995; 60: 1193-1197
        • Thalji N.M.
        • Maltais S.
        • Daly R.C.
        • Greason K.L.
        • Schaff H.V.
        • Dunlay S.M.
        • et al.
        Risk of conventional cardiac surgery among patients with severe left ventricular dysfunction in the era of mechanical circulatory support.
        J Thorac Cardiovasc Surg. 2018; 156: 1530-1540
        • Porepa L.F.
        • Starling R.C.
        Destination therapy with left ventricular assist devices: for whom and when?.
        Can J Cardiol. 2014; 30: 296-303
        • Crespo-Leiro M.G.
        • Metra M.
        • Lund L.H.
        • Milicic D.
        • Costanzo M.R.
        • Filippatos G.
        • et al.
        Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology.
        Eur J Heart Fail. 2018; 20: 1505-1535
        • Kormos R.L.
        • Cowger J.
        • Pagani F.D.
        • Teuteberg J.J.
        • Goldstein D.J.
        • Jacobs J.P.
        • et al.
        The Society of Thoracic Surgeons INTERMACS database annual report: evolving indications, outcomes, and scientific partnerships.
        J Heart Lung Transplant. 2019; 38: 114-126
        • Hayes Jr., D.
        • Cherikh W.S.
        • Chambers D.C.
        • Harhay M.O.
        • Khush K.K.
        • Lehman R.R.
        • et al.
        The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: twenty-second pediatric lung and heart-lung transplantation report–2019; focus theme: donor and recipient size match.
        J Heart Lung Transplant. 2019; 38: 1015-1027
        • Fischer L.G.
        • Van Aken H.
        • Burkle H.
        Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists.
        Anesth Analg. 2003; 96: 1603-1616
        • Price L.C.
        • Wort S.J.
        • Finney S.J.
        • Marino P.S.
        • Brett S.J.
        Pulmonary vascular and right ventricular dysfunction in adult critical care: current and emerging options for management: a systematic literature review.
        Crit Care. 2010; 14: R169
        • Bindslev L.
        • Jolin A.
        • Hedenstierna G.
        • Baehrendtz S.
        • Santesson J.
        Hypoxic pulmonary vasoconstriction in the human lung: effect of repeated hypoxic challenges during anesthesia.
        Anesthesiology. 1985; 62: 621-625
        • Fullerton D.A.
        • Kirson L.E.
        • St Cyr J.A.
        • Albert J.D.
        • Whitman G.J.
        The influence of respiratory acid-base status on adult pulmonary vascular resistance before and after cardiopulmonary bypass.
        Chest. 1993; 103: 1091-1095
        • Fullerton D.A.
        • Kirson L.E.
        • St Cyr J.A.
        • Kinnard T.
        • Whitman G.J.
        Influence of hydrogen ion concentration versus carbon dioxide tension on pulmonary vascular resistance after cardiac operation.
        J Thorac Cardiovasc Surg. 1993; 106: 528-536
        • Jardin F.
        • Vieillard-Baron A.
        Right ventricular function and positive pressure ventilation in clinical practice: from hemodynamic subsets to respirator settings.
        Intensive Care Med. 2003; 29: 1426-1434
        • Khan T.A.
        • Schnickel G.
        • Ross D.
        • Bastani S.
        • Laks H.
        • Esmailian F.
        • et al.
        A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients.
        J Thorac Cardiovasc Surg. 2009; 138: 1417-1424
        • Haraldsson A.
        • Kieler-Jensen N.
        • Nathorst-Westfelt U.
        • Bergh C.H.
        • Ricksten S.E.
        Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
        Chest. 1998; 114: 780-786
        • De Wet C.J.
        • Affleck D.G.
        • Jacobsohn E.
        • Avidan M.S.
        • Tymkew H.
        • Hill L.L.
        • et al.
        Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery.
        J Thorac Cardiovasc Surg. 2004; 127: 1058-1067
        • Arrigo M.
        • Huber L.C.
        • Winnik S.
        • Mikulicic F.
        • Guidetti F.
        • Frank M.
        • et al.
        Right ventricular failure: pathophysiology, diagnosis and treatment.
        Card Fail Rev. 2019; 5: 140-146
        • Samet P.
        • Castillo C.
        • Bernstein W.H.
        Hemodynamic sequelae of atrial, ventricular, and sequential atrioventricular pacing in cardiac patients.
        Am Heart J. 1966; 72: 725-729
        • Hartzler G.O.
        • Maloney J.D.
        • Curtis J.J.
        • Barnhorst D.A.
        Hemodynamic benefits of atrioventricular sequential pacing after cardiac surgery.
        Am J Cardiol. 1977; 40: 232-236
        • Sivak J.A.
        • Raina A.
        • Forfia P.R.
        Assessment of the physiologic contribution of right atrial function to total right heart function in patients with and without pulmonary arterial hypertension.
        Pulm Circ. 2016; 6: 322-328
        • Cannesson M.
        • Farhat F.
        • Scarlata M.
        • Cassar E.
        • Lehot J.J.
        The impact of atrio-biventricular pacing on hemodynamics and left ventricular dyssynchrony compared with atrio-right ventricular pacing alone in the postoperative period after cardiac surgery.
        J Cardiothorac Vasc Anesth. 2009; 23: 306-311
        • Weisse U.
        • Isgro F.
        • Werling C.
        • Lehmann A.
        • Saggau W.
        Impact of atrio-biventricular pacing to poor left-ventricular function after CABG.
        Thorac Cardiovasc Surg. 2002; 50: 131-135
        • Lorusso R.
        • Whitman G.
        • Milojevic M.
        • Raffa G.
        • McMullan D.M.
        • Boeken U.
        • et al.
        2020 EACTS/ELSO/STS/AATS expert consensus on post-cardiotomy extracorporeal life support in adult patients.
        J Thorac Cardiovasc Surg. 2021; 161: 1287-1331
        • Antman E.M.
        • Anbe D.T.
        • Armstrong P.W.
        • Bates E.R.
        • Green L.A.
        • Hand M.
        • et al.
        ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). [Published correction appears in Circulation. 2005;111:2013].
        Circulation. 2004; 110: 588-636
        • Morici N.
        • Oliva F.
        • Ajello S.
        • Stucchi M.
        • Sacco A.
        • Cipriani M.G.
        • et al.
        Management of cardiogenic shock in acute decompensated chronic heart failure: the ALTSHOCK phase II clinical trial.
        Am Heart J. 2018; 204: 196-201
        • McGee M.G.
        • Zillgitt S.L.
        • Trono R.
        • Turner S.A.
        • Davis G.L.
        • Fuqua J.M.
        • et al.
        Retrospective analyses of the need for mechanical circulatory support (intraaortic balloon pump/abdominal left ventricular assist device or partial artificial heart) after cardiopulmonary bypass. A 44 month study of 14,168 patients.
        Am J Cardiol. 1980; 46: 135-142
        • Lorusso R.
        • Raffa G.M.
        • Alenizy K.
        • Sluijpers N.
        • Makhoul M.
        • Brodie D.
        • et al.
        Structured review of post-cardiotomy extracorporeal membrane oxygenation: part 1–adult patients.
        J Heart Lung Transplant. 2019; 38: 1125-1143
        • Bochaton T.
        • Huot L.
        • Elbaz M.
        • Delmas C.
        • Aissaoui N.
        • Farhat F.
        • et al.
        Mechanical circulatory support with the Impella LP5.0 pump and an intra-aortic balloon pump for cardiogenic shock in acute myocardial infarction: the IMPELLA-STIC randomized study.
        Arch Cardiovasc Dis. 2020; 113: 237-243
        • Pennington D.G.
        • Swartz M.
        • Codd J.E.
        • Merjavy J.P.
        • Kaiser G.C.
        Intraaortic balloon pumping in cardiac surgical patients: a nine-year experience.
        Ann Thorac Surg. 1983; 36: 125-131
        • Boeken U.
        • Feindt P.
        • Litmathe J.
        • Kurt M.
        • Gams E.
        Intraaortic balloon pumping in patients with right ventricular insufficiency after cardiac surgery: parameters to predict failure of IABP support.
        Thorac Cardiovasc Surg. 2009; 57: 324-328
        • Engstrom A.E.
        • Granfeldt H.
        • Seybold-Epting W.
        • Dahm M.
        • Cocchieri R.
        • Driessen A.H.
        • et al.
        Mechanical circulatory support with the Impella 5.0 device for postcardiotomy cardiogenic shock: a three-center experience.
        Minerva Cardioangiol. 2013; 61: 539-546
        • David C.H.
        • Quessard A.
        • Mastroianni C.
        • Hekimian G.
        • Amour J.
        • Leprince P.
        • et al.
        Mechanical circulatory support with the Impella 5.0 and the Impella Left Direct pumps for postcardiotomy cardiogenic shock at La Pitie-Salpetriere Hospital.
        Eur J Cardiothorac Surg. 2020; 57: 183-188
        • Griffith B.P.
        • Anderson M.B.
        • Samuels L.E.
        • Pae Jr., W.E.
        • Naka Y.
        • Frazier O.H.
        The RECOVER I: a multicenter prospective study of Impella 5.0/LD for postcardiotomy circulatory support.
        J Thorac Cardiovasc Surg. 2013; 145: 548-554
        • Seyfarth M.
        • Sibbing D.
        • Bauer I.
        • Frohlich G.
        • Bott-Flugel L.
        • Byrne R.
        • et al.
        A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.
        J Am Coll Cardiol. 2008; 52: 1584-1588
        • Ouweneel D.M.
        • Eriksen E.
        • Sjauw K.D.
        • van Dongen I.M.
        • Hirsch A.
        • Packer E.J.
        • et al.
        Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction.
        J Am Coll Cardiol. 2017; 69: 278-287
        • Rastan A.J.
        • Dege A.
        • Mohr M.
        • Doll N.
        • Falk V.
        • Walther T.
        • et al.
        Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock.
        J Thorac Cardiovasc Surg. 2010; 139: 302-311
        • Elsharkawy H.A.
        • Li L.
        • Esa W.A.
        • Sessler D.I.
        • Bashour C.A.
        Outcome in patients who require venoarterial extracorporeal membrane oxygenation support after cardiac surgery.
        J Cardiothorac Vasc Anesth. 2010; 24: 946-951
        • Wang L.
        • Wang H.
        • Hou X.
        Clinical outcomes of adult patients who receive extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock: a systematic review and meta-analysis.
        J Cardiothorac Vasc Anesth. 2018; 32: 2087-2093
        • Mariscalco G.
        • Salsano A.
        • Fiore A.
        • Dalen M.
        • Ruggieri V.G.
        • Saeed D.
        • et al.
        Peripheral versus central extracorporeal membrane oxygenation for postcardiotomy shock: multicenter registry, systematic review, and meta-analysis.
        J Thorac Cardiovasc Surg. 2020; 160: 1207-1216
        • Schrage B.
        • Becher P.M.
        • Bernhardt A.
        • Bezerra H.
        • Blankenberg S.
        • Brunner S.
        • et al.
        Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: results from an international, multicenter cohort study.
        Circulation. 2020; 142: 2095-2106
        • Russo J.J.
        • Aleksova N.
        • Pitcher I.
        • Couture E.
        • Parlow S.
        • Faraz M.
        • et al.
        Left ventricular unloading during extracorporeal membrane oxygenation in patients with cardiogenic shock.
        J Am Coll Cardiol. 2019; 73: 654-662
        • Murphy S.P.
        • Ibrahim N.E.
        • Januzzi Jr., J.L.
        Heart failure with reduced ejection fraction: a review.
        JAMA. 2020; 324: 488-504
        • Hernandez A.F.
        • Greiner M.A.
        • Fonarow G.C.
        • Hammill B.G.
        • Heidenreich P.A.
        • Yancy C.W.
        • et al.
        Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure.
        JAMA. 2010; 303: 1716-1722
        • Farskey P.
        • White J.
        • Al-Khalidi H.R.
        • Sueta C.A.
        • Rouleau J.L.
        • Panza J.A.
        • et al.
        Optimal medical therapy with or without surgical revascularization and long-term outcomes in ischemic cardiomyopathy.
        J Thorac Cardiovasc Surg. January 7, 2021; ([Epub ahead of print])
        • McMurray J.J.
        • Packer M.
        • Desai A.S.
        • Gong J.
        • Lefkowitz M.P.
        • Rizkala A.R.
        • et al.
        Angiotensin-neprilysin inhibition versus enalapril in heart failure.
        N Engl J Med. 2014; 371: 993-1004
        • Velazquez E.J.
        • Morrow D.A.
        • DeVore A.D.
        • Duffy C.I.
        • Ambrosy A.P.
        • McCague K.
        • et al.
        Angiotensin-neprilysin inhibition in acute decompensated heart failure.
        N Engl J Med. 2019; 380: 539-548
        • McMurray J.J.V.
        • Solomon S.D.
        • Inzucchi S.E.
        • Kober L.
        • Kosiborod M.N.
        • Martinez F.A.
        • et al.
        Dapagliflozin in patients with heart failure and reduced ejection fraction.
        N Engl J Med. 2019; 381: 1995-2008
        • Packer M.
        • Anker S.D.
        • Butler J.
        • Filippatos G.
        • Pocock S.J.
        • Carson P.
        • et al.
        Cardiovascular and renal outcomes with empagliflozin in heart failure.
        N Engl J Med. 2020; 383: 1413-1424
        • Wu C.
        • Hannan E.L.
        • Ryan T.J.
        • Bennett E.
        • Culliford A.T.
        • Gold J.P.
        • et al.
        Is the impact of hospital and surgeon volumes on the in-hospital mortality rate for coronary artery bypass graft surgery limited to patients at high risk?.
        Circulation. 2004; 110: 784-789
        • Kumbhani D.J.
        • Fonarow G.C.
        • Heidenreich P.A.
        • Schulte P.J.
        • Lu D.
        • Hernandez A.
        • et al.
        Association between hospital volume, processes of care, and outcomes in patients admitted with heart failure: insights from get with the guidelines–heart failure.
        Circulation. 2018; 137: 1661-1670
        • Nashef S.A.
        • Roques F.
        • Sharples L.D.
        • Nilsson J.
        • Smith C.
        • Goldstone A.R.
        • et al.
        EuroSCORE II.
        Eur J Cardiothorac Surg. 2012; 41: 734-745
        • Bouabdallaoui N.
        • Stevens S.R.
        • Doenst T.
        • Petrie M.C.
        • Al-Attar N.
        • Ali I.S.
        • et al.
        Society of Thoracic Surgeons Risk Score and EuroSCORE-2 appropriately assess 30-day postoperative mortality in the STICH trial and a contemporary cohort of patients with left ventricular dysfunction undergoing surgical revascularization.
        Circ Heart Fail. 2018; 11: e005531
        • Vallakati A.
        • Hasan A.K.
        • Boudoulas K.D.
        Transcatheter mitral valve repair in patients with heart failure: a meta-analysis.
        Cardiology. 2021; 146: 42-48
        • Stone G.W.
        • Lindenfeld J.
        • Abraham W.T.
        • Kar S.
        • Lim D.S.
        • Mishell J.M.
        • et al.
        Transcatheter mitral-valve repair in patients with heart failure.
        N Engl J Med. 2018; 379: 2307-2318
        • Madonna R.
        • Van Laake L.W.
        • Davidson S.M.
        • Engel F.B.
        • Hausenloy D.J.
        • Lecour S.
        • et al.
        Position paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.
        Eur Heart J. 2016; 37: 1789-1798
        • Bekfani T.
        • Fudim M.
        • Cleland J.G.F.
        • Jorbenadze A.
        • von Haehling S.
        • Lorber A.
        • et al.
        A current and future outlook on upcoming technologies in remote monitoring of patients with heart failure.
        Eur J Heart Fail. 2021; 23: 175-185